It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Plant cell wall hydrolysates contain not only sugars but also substantial amounts of acetate, a fermentation inhibitor that hinders bioconversion of lignocellulose. Despite the toxic and non-consumable nature of acetate during glucose metabolism, we demonstrate that acetate can be rapidly co-consumed with xylose by engineered Saccharomyces cerevisiae. The co-consumption leads to a metabolic re-configuration that boosts the synthesis of acetyl-CoA derived bioproducts, including triacetic acid lactone (TAL) and vitamin A, in engineered strains. Notably, by co-feeding xylose and acetate, an enginered strain produces 23.91 g/L TAL with a productivity of 0.29 g/L/h in bioreactor fermentation. This strain also completely converts a hemicellulose hydrolysate of switchgrass into 3.55 g/L TAL. These findings establish a versatile strategy that not only transforms an inhibitor into a valuable substrate but also expands the capacity of acetyl-CoA supply in S. cerevisiae for efficient bioconversion of cellulosic biomass.
Cellulosic hydrolysates contain substantial amounts of acetate, which is toxic to fermenting microorganisms. Here, the authors engineer Baker’s yeast to co-consume xylose and acetate for triacetic acid lactone production from a hemicellulose hydrolysate of switchgrass.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 University of Illinois at Urbana-Champaign, Department of Food Science and Human Nutrition, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of Illinois at Urbana-Champaign, Carl R. Woese Institute for Genomic Biology, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of Illinois at Urbana-Champaign, DOE Center for Advanced Bioenergy and Bioproducts Innovation, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)
2 University of Illinois at Urbana-Champaign, Department of Food Science and Human Nutrition, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)
3 Kyungpook National University, School of Food Science and Biotechnology, Daegu, South Korea (GRID:grid.258803.4) (ISNI:0000 0001 0661 1556)